Growth Metrics

Whitehawk Therapeutics (WHWK) Net Cash Flow Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 89.97%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -13.44%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 33.37%
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -29.82%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 32.17%
10 Whitehawk Therapeutics 312.26 Mn 189.22 Mn - 17.64%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 17.64%
Dec 31, 2025 84.41%
Sep 30, 2025 -105.32%
Jun 30, 2025 -95.56%
Mar 31, 2025 131.39%
Dec 31, 2024 46.78%
Sep 30, 2024 -27.46%
Jun 30, 2024 -57.16%
Mar 31, 2024 -41.89%
Dec 31, 2023 -21.78%
Sep 30, 2023 26.84%
Jun 30, 2023 49.10%
Mar 31, 2023 -8.07%
Dec 31, 2022 -170.03%
Sep 30, 2022 75.14%
Jun 30, 2022 -28.02%
Mar 31, 2022 -27.70%
Dec 31, 2021 -25.99%
Sep 30, 2021 1,739.33%
Jun 30, 2021 -27.22%
Mar 31, 2021 53.77%
Dec 31, 2020 10.48%
Sep 30, 2020 -57.78%
Jun 30, 2020 53.77%
Mar 31, 2020 -28.41%
Dec 31, 2019 -162.77%
Sep 30, 2019 -152.99%
Jun 30, 2019 -9.82%
Mar 31, 2019 -32.14%
Dec 31, 2018 -697.49%
Sep 30, 2018 102.38%
Jun 30, 2018 1,509.92%
Mar 31, 2018 -613.12%
Dec 31, 2017 -612.81%
Sep 30, 2017 -1,231.90%
Jun 30, 2017 -1,585.01%
Mar 31, 2017 4,276.49%
Dec 31, 2016 325.64%
Sep 30, 2016 -230.91%
Jun 30, 2016 -534.10%
Mar 31, 2016 -1,179.67%
Dec 31, 2015 160.30%
Sep 30, 2015 0.81%
Jun 30, 2015 2.62%
Mar 31, 2015 -2.54%
Dec 31, 2014 -84.56%
Sep 30, 2014 18.13%
Jun 30, 2014 55.97%
Mar 31, 2014 43.89%
Dec 31, 2013 -29.32%
Sep 30, 2013 -32.33%